These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


507 related items for PubMed ID: 9893931

  • 1. Effects of BX661A, a new therapeutic agent for ulcerative colitis, on chemotaxis and reactive oxygen species production in polymorphonuclear leukocytes in comparison with salazosulfapyridine and its metabolite sulfapyridine.
    Kimura I, Kawasaki M, Matsuda A, Kataoka M, Kokurba Y.
    Arzneimittelforschung; 1998 Dec; 48(12):1163-7. PubMed ID: 9893931
    [Abstract] [Full Text] [Related]

  • 2. Effects of BX661A, a new therapeutic agent for ulcerative colitis, on reactive oxygen species in comparison with salazosulfapyridine and its metabolite sulfapyridine.
    Kimura I, Kumamoto T, Matsuda A, Kataoka M, Kokuba Y.
    Arzneimittelforschung; 1998 Oct; 48(10):1007-11. PubMed ID: 9825118
    [Abstract] [Full Text] [Related]

  • 3. Determination of the active moiety of BX661A, a new therapeutic agent for ulcerative colitis, by studying its therapeutic effects on ulcerative colitis induced by dextran sulfate sodium in rats.
    Kimura I, Kawasaki M, Nagahama S, Matsuda A, Kataoka M, Kokuba Y.
    Arzneimittelforschung; 1998 Nov; 48(11):1091-6. PubMed ID: 9850431
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Influences of aflatoxin B1 on reactive oxygen species generation and chemotaxis of human polymorphonuclear leukocytes.
    Ubagai T, Tansho S, Ito T, Ono Y.
    Toxicol In Vitro; 2008 Jun; 22(4):1115-20. PubMed ID: 18316174
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Effect of sulphasalazine and its metabolites on the generation of reactive oxygen species.
    Miyachi Y, Yoshioka A, Imamura S, Niwa Y.
    Gut; 1987 Feb; 28(2):190-5. PubMed ID: 2881849
    [Abstract] [Full Text] [Related]

  • 10. Effects of grepafloxacin on the function of human polymorphonuclear leukocytes and the phosphorylation of p38 mitogen-activated protein kinase.
    Koshio O, Ono Y.
    Chemotherapy; 2009 Feb; 55(5):363-71. PubMed ID: 19657190
    [Abstract] [Full Text] [Related]

  • 11. Pharmacologic actions of the second-generation leukotriene B4 receptor antagonist LY293111: in vitro studies.
    Jackson WT, Froelich LL, Boyd RJ, Schrementi JP, Saussy DL, Schultz RM, Sawyer JS, Sofia MJ, Herron DK, Goodson T, Snyder DW, Pechous PA, Spaethe SM, Roman CR, Fleisch JH.
    J Pharmacol Exp Ther; 1999 Jan; 288(1):286-94. PubMed ID: 9862783
    [Abstract] [Full Text] [Related]

  • 12. Preparation and characterization of a derivative of wheat germ agglutinin which specifically inhibits polymorphonuclear leukocyte chemotaxis to the synthetic chemotactic peptide N-formyl-methionyl-leucyl-phenylalanine.
    Perez HD, Elfman F, Chenoweth D, Hooper C.
    J Immunol; 1986 Mar 01; 136(5):1813-9. PubMed ID: 3753994
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Effect of erythromycin on bronchial hyperresponsiveness in patients with bronchial asthma.
    Miyatake H, Suzuki K, Taki F, Takagi K, Satake T.
    Arzneimittelforschung; 1991 May 01; 41(5):552-6. PubMed ID: 1654910
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 26.